Leflunomide in Previously Treated Metastatic Triple Negative Cancers
NCT03709446
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Breast Diseases
Metastatic Triple Negative Breast Cancer
Interventions
DRUG:
Leflunomide
Sponsor
Joseph Sparano